Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 96.00 | |
5 mg | In stock | $ 239.00 | |
10 mg | In stock | $ 378.00 | |
25 mg | In stock | $ 639.00 | |
50 mg | In stock | $ 913.00 | |
100 mg | In stock | $ 1,230.00 | |
500 mg | In stock | $ 2,490.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 263.00 |
Description | Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM). |
Targets&IC50 | c-Kit:0.1-1 μM , c-FMS/CSF-IR:<0.01 μM |
In vitro | DCC-3014 has anti-cancer and anti-proliferative activities. |
Synonyms | DCC-3014 |
Molecular Weight | 431.49 |
Formula | C23H25N7O2 |
CAS No. | 1628606-05-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 73 mg/mL (169.18 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vimseltinib 1628606-05-2 Tyrosine Kinase/Adaptors c-Fms c-Kit CSF-1R CSF1R CD117 CSF-1 receptor DCC 3014 SCFR inhibit DCC3014 DCC-3014 colony stimulating factor 1 receptor Inhibitor inhibitor